GNRX

VanEck Vectors Generic Drugs ETF
GNRX

Overview Fund Activity
Delisted

GNRX was delisted on the 4th of April, 2019.

Back to rankings

1 hedge funds and large institutions have $163K invested in VanEck Vectors Generic Drugs ETF in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
APA
American Portfolios Advisors
New York
-$11.4K
Name Holding Trade Value Shares
Change 		Shares
Change %
APA
1
American Portfolios Advisors
New York
$163K -$11.4K -450 -7%